- Home
- TLSI vs CTRN Comparison
TLSI vs CTRN Comparison
Compare TLSI & CTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- CTRN
- Stock Information
- Founded
- TLSI 2010
- CTRN 1946
- Country
- TLSI United States
- CTRN United States
- Employees
- TLSI N/A
- CTRN N/A
- Industry
- TLSI Medical Specialities
- CTRN Clothing/Shoe/Accessory Stores
- Sector
- TLSI Health Care
- CTRN Consumer Discretionary
- Exchange
- TLSI Nasdaq
- CTRN Nasdaq
- Market Cap
- TLSI 244.3M
- CTRN 270.0M
- IPO Year
- TLSI N/A
- CTRN 2005
- Fundamental
- Price
- TLSI $4.73
- CTRN $31.16
- Analyst Decision
- TLSI Strong Buy
- CTRN Buy
- Analyst Count
- TLSI 4
- CTRN 2
- Target Price
- TLSI $11.13
- CTRN $31.50
- AVG Volume (30 Days)
- TLSI 118.6K
- CTRN 88.5K
- Earning Date
- TLSI 11-13-2025
- CTRN 08-26-2025
- Dividend Yield
- TLSI N/A
- CTRN N/A
- EPS Growth
- TLSI N/A
- CTRN N/A
- EPS
- TLSI N/A
- CTRN N/A
- Revenue
- TLSI $35,990,000.00
- CTRN $782,716,000.00
- Revenue This Year
- TLSI $56.79
- CTRN $7.81
- Revenue Next Year
- TLSI $54.15
- CTRN $4.94
- P/E Ratio
- TLSI N/A
- CTRN N/A
- Revenue Growth
- TLSI 45.50
- CTRN 3.32
- 52 Week Low
- TLSI $3.42
- CTRN $16.18
- 52 Week High
- TLSI $5.88
- CTRN $39.37
- Technical
- Relative Strength Index (RSI)
- TLSI 48.36
- CTRN 43.99
- Support Level
- TLSI $4.42
- CTRN $29.60
- Resistance Level
- TLSI $4.67
- CTRN $33.09
- Average True Range (ATR)
- TLSI 0.23
- CTRN 1.49
- MACD
- TLSI -0.03
- CTRN -0.13
- Stochastic Oscillator
- TLSI 61.87
- CTRN 32.50
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About CTRN Citi Trends Inc.
Citi Trends Inc is a retailer of urban fashion apparel and accessories in the United States. The company offers apparel, including fashion sportswear for men and women, as well as children, such as newborns, infants, toddlers, boys, and girls; accessories comprising handbags, jewelry, footwear, belts, intimate apparel, scrubs, and sleepwear; and functional and decorative home products, as well as beauty products, books and toys.